171 related articles for article (PubMed ID: 28719625)
41. Network-Based Analysis for Uncovering Mechanisms Underlying Alzheimer's Disease.
Kikuchi M; Ogishima S; Mizuno S; Miyashita A; Kuwano R; Nakaya J; Tanaka H
Methods Mol Biol; 2016; 1303():479-91. PubMed ID: 26235086
[TBL] [Abstract][Full Text] [Related]
42. Quantitative inference of dynamic regulatory pathways via microarray data.
Chang WC; Li CW; Chen BS
BMC Bioinformatics; 2005 Mar; 6():44. PubMed ID: 15748298
[TBL] [Abstract][Full Text] [Related]
43. Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: statistical reliability and functional correlation.
Blalock EM; Chen KC; Stromberg AJ; Norris CM; Kadish I; Kraner SD; Porter NM; Landfield PW
Ageing Res Rev; 2005 Nov; 4(4):481-512. PubMed ID: 16257272
[TBL] [Abstract][Full Text] [Related]
44. Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes.
Sekar S; McDonald J; Cuyugan L; Aldrich J; Kurdoglu A; Adkins J; Serrano G; Beach TG; Craig DW; Valla J; Reiman EM; Liang WS
Neurobiol Aging; 2015 Feb; 36(2):583-91. PubMed ID: 25448601
[TBL] [Abstract][Full Text] [Related]
45. Sense-antisense gene-pairs in breast cancer and associated pathological pathways.
Grinchuk OV; Motakis E; Yenamandra SP; Ow GS; Jenjaroenpun P; Tang Z; Yarmishyn AA; Ivshina AV; Kuznetsov VA
Oncotarget; 2015 Dec; 6(39):42197-221. PubMed ID: 26517092
[TBL] [Abstract][Full Text] [Related]
46. Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple Sclerosis.
Borjabad A; Volsky DJ
J Neuroimmune Pharmacol; 2012 Dec; 7(4):914-26. PubMed ID: 23065460
[TBL] [Abstract][Full Text] [Related]
47. Cancer and Alzheimer's Inverse Correlation: an Immunogenetic Analysis.
Bhardwaj A; Liyanage SI; Weaver DF
Mol Neurobiol; 2023 Jun; 60(6):3086-3099. PubMed ID: 36797545
[TBL] [Abstract][Full Text] [Related]
48. Alzheimer's disease and HLA-A2: linking neurodegenerative to immune processes through an in silico approach.
Cifuentes RA; Murillo-Rojas J
Biomed Res Int; 2014; 2014():791238. PubMed ID: 25197660
[TBL] [Abstract][Full Text] [Related]
49. RCAN1 in the inverse association between Alzheimer's disease and cancer.
Fu Q; Wu Y
Oncotarget; 2018 Jan; 9(1):54-66. PubMed ID: 29416595
[TBL] [Abstract][Full Text] [Related]
50. Molecular Inverse Comorbidity between Alzheimer's Disease and Lung Cancer: New Insights from Matrix Factorization.
Greco A; Sanchez Valle J; Pancaldi V; Baudot A; Barillot E; Caselle M; Valencia A; Zinovyev A; Cantini L
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31247897
[TBL] [Abstract][Full Text] [Related]
51. Assessment of gene order computing methods for Alzheimer's disease.
Hu B; Jiang G; Pang C; Wang S; Liu Q; Chen Z; Vanderburg CR; Rogers JT; Deng Y; Huang X
BMC Med Genomics; 2013; 6 Suppl 1(Suppl 1):S8. PubMed ID: 23369541
[TBL] [Abstract][Full Text] [Related]
52. Deconstructing development.
Harly C; Wherry EJ; Bhandoola A
Nat Immunol; 2013 Jun; 14(6):529-31. PubMed ID: 23685815
[No Abstract] [Full Text] [Related]
53. Orchestration of the immune response: multilevel regulation of diverse regulatory processes.
Swain SL; Cambier JC
Curr Opin Immunol; 1996 Jun; 8(3):309-11. PubMed ID: 8794003
[No Abstract] [Full Text] [Related]
54. Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease.
Lai AY; McLaurin J
J Neurochem; 2018 Mar; 144(5):659-668. PubMed ID: 28722749
[TBL] [Abstract][Full Text] [Related]
55. A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression.
Llano DA; Bundela S; Mudar RA; Devanarayan V;
PLoS One; 2017; 12(8):e0182098. PubMed ID: 28771542
[TBL] [Abstract][Full Text] [Related]
56. Genetics of disease severity in multiple sclerosis, Alzheimer's disease, and Huntington's disease: rejuvenating genome-wide association studies.
Hrastelj J; Robertson N
J Neurol; 2017 Sep; 264(9):2040-2042. PubMed ID: 28785799
[No Abstract] [Full Text] [Related]
57. Investigating the genetic relationship between Alzheimer's disease and cancer using GWAS summary statistics.
Feng YA; Cho K; Lindstrom S; Kraft P; Cormack J; ; ; ; ; Liang L; Driver JA
Hum Genet; 2017 Oct; 136(10):1341-1351. PubMed ID: 28780673
[TBL] [Abstract][Full Text] [Related]
58. Transthyretin neuroprotection in Alzheimer's disease is dependent on proteolysis.
Silva CS; Eira J; Ribeiro CA; Oliveira Â; Sousa MM; Cardoso I; Liz MA
Neurobiol Aging; 2017 Nov; 59():10-14. PubMed ID: 28780366
[TBL] [Abstract][Full Text] [Related]
59. Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease.
Drolle E; Negoda A; Hammond K; Pavlov E; Leonenko Z
PLoS One; 2017; 12(8):e0182194. PubMed ID: 28767712
[TBL] [Abstract][Full Text] [Related]
60. Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases.
Alam Q; Alam MZ; Sait KHW; Anfinan N; Noorwali AW; Kamal MA; Khan MSA; Haque A
Curr Drug Metab; 2017; 18(9):868-876. PubMed ID: 28758577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
